Results 1 to 10 of about 755,388 (347)

KLHL14: A Novel Prognostic Biomarker and Therapeutic Target for Ovarian Cancer [PDF]

, 2022
Xingwei Wang, Ru Sun, H. Amy Xia, Chen Chen, Yan Ding   +4 more
openalex   +1 more source

The Ovary Is an Alternative Site of Origin for High-Grade Serous Ovarian Cancer in Mice

, 2015
Jaeyeon Kim, Donna Coffey, Lang Ma, Martin M. Matzuk   +3 more
openalex   +1 more source

A Single-Center, Retrospective Study of Bevacizumab-Containing Neoadjuvant Chemotherapy followed by Interval Debulking Surgery for Ovarian Cancer [PDF]

, 2020
Junsik Park, Kyung Jin Eoh, Eun Ji Nam, Sunghoon Kim, Sang Wun Kim, Young Tae Kim, Jung‐Yun Lee   +6 more
openalex   +1 more source

18 Efficacy of maintenance olaparib plus bevacizumab by biomarker status in clinical higher- and lower-risk patients with newly diagnosed, advanced ovarian cancer in the PAOLA-1 trial [PDF]

, 2020
Philipp Harter, Daniela Petran, Giovanni Scambia, E. Ortega, Irina Tsibulak, Shoji Nagao, Ignace Vergote, Jérôme Meunier, Franck Priou, Robert Sverdlin, Tsveta Milenkova, I. L. Ray-Coquard, I. L. Ray-Coquard   +12 more
openalex   +1 more source

Author Correction: Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation

Nature Communications, 2022
Yiyan Zheng, Ritika Sethi, Lingegowda S. Mangala, Charlotte Taylor, Juliet Goldsmith, Ming Wang, Kenta Masuda, Eli M. Carrami, David Mannion, Fabrizio Miranda, Sandra Herrero-Gonzalez, Karin Hellner, Fiona Chen, Abdulkhaliq Alsaadi, Ashwag Albukhari, Donatien Chedom Fotso, Christopher Yau, Dahai Jiang, Sunila Pradeep, Cristian Rodriguez-Aguayo, Gabriel Lopez-Berestein, Stefan Knapp, Nathanael S. Gray, Leticia Campo, Kevin A. Myers, Sunanda Dhar, David Ferguson, Robert C. Bast, Anil K. Sood, Frank von Delft, Ahmed Ashour Ahmed   +30 more
doaj   +1 more source

A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab and veliparib in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: An NRG Oncology/Gynecologic Oncology Group study

, 2015
Lisa M. Landrum, William E. Brady, Deborah K. Armstrong, Kathleen N. Moore, Paul DiSilvestro, David M. O’Malley, Meaghan Tenney, Peter G. Rose, Paula M. Fracasso   +8 more
openalex   +1 more source

The Genetic and Molecular Analyses of RAD51C and RAD51D Identifies Rare Variants Implicated in Hereditary Ovarian Cancer from a Genetically Unique Population [PDF]

, 2022
Wejdan M. Alenezi, Larissa Milano, Caitlin T. Fierheller, Corinne Serruya, Timothée Revil, Kathleen Klein Oros, Supriya Behl, Suzanna L. Arcand, Porangana Nayar, Dan Spiegelman, Simon Gravel, Anne‐Marie Mes‐Masson, Diane Provencher, William D. Foulkes, Zaki El Haffaf, Guy A. Rouleau, Luigi Bouchard, Celia M.T. Greenwood, Jean‐Yves Masson, Jiannis Ragoussis, Patricia N. Tonin   +20 more
openalex   +1 more source

Regular Physical Inactivity and Ovarian Cancer Risk in the Ovarian Cancer in Women of African Ancestry Consortium. [PDF]

Cancer Epidemiol Biomarkers Prev
Lima SM, Minlikeeva AN, Johnson CE, Guertin KA, Bandera EV, Zheng W, Bethea TN, Petrick JL, Joslin CE, Myers ER, Harris HR, Peres LC, Setiawan VW, Wu AH, Rosenberg L, Schildkraut JM, Ochs-Balcom HM.   +16 more
europepmc   +1 more source

EIF5A1 promotes epithelial ovarian cancer proliferation and progression

, 2018
Jing Zhang, Xiao Li, Xiaorui Liu, Fu‐Ju Tian, Weihong Zeng, Xiaowei Xi, Yi Lin   +6 more
openalex   +1 more source

Low prevalence of (pre) malignant lesions in the breast and high prevalence in the ovary and Fallopian tube in women at hereditary high risk of breast and ovarian cancer [PDF]

, 2006
Brenda Hermsen, P. J. van Diest, Johannes Berkhof, Fred H. Menko, Gilles Thomas, Jurgen M.J. Piek, Sybren Meijer, Henri A. H. Winters, Peter Kenemans, Silvia von Mensdorff‐Pouilly, René H.M. Verheijen   +10 more
openalex   +1 more source